What infectious agents cause diarrhea in immunocompromised cancer patients?

Infectious Causes of Diarrhea in Immunocompromised Cancer Patients

The most common infectious causes of diarrhea in immunocompromised cancer patients are Clostridioides difficile, norovirus, and cytomegalovirus, with additional important pathogens including Cryptosporidium, Cyclospora, enteropathogenic E. coli, and Blastocystis. 1, 2

Primary Bacterial Pathogens

Clostridioides difficile

• C. difficile represents the most frequently identified bacterial cause of diarrhea in immunocompromised cancer patients 1, 2
• Risk is particularly elevated in patients with recent antibiotic exposure or hospitalization ≥3 days prior to symptom onset 3

Enteropathogenic Escherichia coli (EPEC)

• EPEC causes community-acquired diarrhea in cancer patients with significantly higher bacterial burden in immunosuppressed individuals (median 6.7 × 10³ vs. 55 bacteria/mg stool) 4
• Antimicrobial resistance is common, and response to therapy occurs in 92% of patients when EPEC is the sole pathogen 4
• Cancer care was delayed in 13% of patients with EPEC-associated diarrhea 4
• Different E. coli pathotypes were observed in 17 patients in one study of immune checkpoint inhibitor-related diarrhea 5

Viral Pathogens

Norovirus

• Norovirus is one of the three most common infectious causes of diarrhea in immunocompromised patients 1, 2
• Viral infections including adenovirus, norovirus, and sapovirus have been documented in cancer patients with diarrhea 5

Cytomegalovirus (CMV)

• CMV represents a feared opportunistic pathogen causing colitis in immunosuppressed cancer patients, particularly those on immunosuppressive medications like mycophenolate mofetil 1, 2, 6
• CMV infection can affect multiple organ systems but commonly involves the gastrointestinal tract 6

Parasitic Protozoan Infections

Coccidian Parasites

• The prevalence of coccidian parasites (Cryptosporidium, Cyclospora, and Cystoisospora) reaches 35.4% in immunocompromised children with cancer using combined detection methods 7
• Cryptosporidium was present in 22.5% of cases, Cyclospora in 9.6%, and Cystoisospora in 3.2% 7
• Immunosuppression therapy may exacerbate symptoms related to these parasitic infections 7

Enterocytozoon bieneusi and Blastocystis

• E. bieneusi infection rate was 1.3% and Blastocystis 7.1% in cancer patients 8
• Both pathogens were significantly more common in cancer patients with diarrhea, and Blastocystis showed significant relationship to diarrhea specifically in the chemotherapy group 8
• Genotypes identified suggest potential for zoonotic transmission 8

Other Intestinal Parasites

• Giardia, Blastocystis, and Entamoeba coli were detected in immunocompromised children with malignancies 7

Diagnostic Approach

When to Test

• Obtain laboratory testing for cancer patients with diarrhea lasting ≥3 days, fever, bloody stools, severe dehydration, recent antibiotic use, hospitalization ≥3 days prior to symptom onset, or immunocompromised state 3
• The National Comprehensive Cancer Network recommends a lower threshold for testing in immunocompromised or neutropenic patients, including blood cultures and coagulation tests 3

Diagnostic Methods

• Gastrointestinal multiplex PCR panels allow rapid, sensitive detection of a wide range of pathogens in a single assay and have improved diagnostic yield 1, 2
• However, use these panels judiciously to avoid over-testing, overtreatment, and increased costs, as they may identify colonizing pathogens that are not pathogenic 1, 2
• Traditional microscopic examination combined with PCR provides optimal detection of coccidian parasites 7
• Quantitative PCR can differentiate colonization from true infection, with bacterial burden >55 bacteria/mg stool suggesting pathogenic infection 4

Critical Clinical Considerations

Impact on Cancer Treatment

• Diarrhea in cancer patients leads to higher rates of therapy discontinuation (82.4% vs. 64.6%), shorter time to discontinuation (59.6 vs. 68.3 days), and lower adherence (25.5% vs. 47.9%) 9
• Cancer care may be delayed in patients with infectious diarrhea 4

Concomitant Infections

• Gastrointestinal infections co-occurring with immune-mediated diarrhea and colitis are associated with more severe symptoms (grade 3-4 colitis in 43% vs. 18%) 5
• Antimicrobial treatment for concomitant infections did not circumvent the need for immunosuppressive therapy or improve clinical outcomes 5

Common Pitfalls to Avoid

• Do not rely solely on single pathogen assays when multiplex panels are available, as they significantly improve diagnostic yield 1, 2
• Avoid interpreting positive multiplex PCR results as definitively pathogenic without considering clinical context and quantitative burden 1, 2
• Do not delay appropriate infectious workup in neutropenic patients, as the NCCN Guidelines emphasize lower testing thresholds in this population 3
• Remember that both infectious and non-infectious causes (immunosuppressive drugs, mucositis) commonly cause diarrhea in cancer patients 1